Search for Clinical Trial Results

Sponsored By

Hypereosinophilic Syndrome - 14 Studies Found

Status Study
Completed Study Name: 2-Chlorodeoxyadenosine and Cytarabine in Patients With Idiopathic Hypereosinophilic Syndrome (HES)
Condition: Leukemia
Date: 2007-06-05
Interventions:
  • Drug: 2-CdA 12 mg/m^2/day by v
Completed Study Name: Therapy of HES, PV, Atypical Chronic Myelocytic Leukemia (CML) or Chronic Myelomonocytic Leukemia (CMML), and Mastocytosis With Imatinib Mesylate
Condition:
  • Chronic Myelomonocytic Leukemia
  • Chronic Myeloid Leukemia
  • P
    Date: 2002-06-04
    Interventions: Drug: Imatinib Mesylate (Gleevec) Imatinib mesylate 400 mg orally daily, and in HES patients start with
Completed Study Name: Dasatinib as Therapy for Myeloproliferative Disorders (MPDs)
Condition:
  • Acute Myeloid Leukemia
  • Myelodysplastic Syndromes
  • Agnogenic
    Date: 2005-11-16
    Interventions: Drug: Dasatinib (BMS-354825) 70 mg orally twice daily
Completed Study Name: A Study of Oral AMN107 in Adults With Chronic Myelogenous Leukemia (CML) or Other Blood Related Cancers
Condition:
  • Chronic Myelogenous Leukemia
  • Acute Lymphoblastic Leukemia (Philadelphia Chromosome Positive)
    Date: 2005-05-02
    Interventions: Drug: Nilotinib
<<< Previous